Screener
Monopar Therapeutics MNPR Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Monopar Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Monopar Therapeutics’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 2:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-016982
FAQ
- What is Monopar Therapeutics's return on invested capital?
- Monopar Therapeutics (MNPR) reported return on invested capital of -38.6% in Q1 2026.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Monopar Therapeutics's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude